Personalised therapeutic approaches to glioblastoma: A systematic review.

Mowforth, Oliver D; Brannigan, Jamie; El Khoury, Marc; Sarathi, Celine Iswarya Partha; Bestwick, Harry; Bhatti, Faheem; Mair, Richard

Mowforth, Oliver D; Brannigan, Jamie; El Khoury, Marc; Sarathi, Celine Iswarya Partha; Bestwick, Harry; Bhatti, Faheem; Mair, Richard.

Afiliación

Mowforth OD; Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, England, United Kingdom.
Brannigan J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, England, United Kingdom.
El Khoury M; Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, England, United Kingdom.
Sarathi CIP; School of Clinical Medicine, University of Cambridge, Cambridge, England, United Kingdom.
Bestwick H; School of Clinical Medicine, University of Cambridge, Cambridge, England, United Kingdom.
Bhatti F; School of Clinical Medicine, University of Cambridge, Cambridge, England, United Kingdom.
Mair R; School of Clinical Medicine, University of Cambridge, Cambridge, England, United Kingdom.

Front Med (Lausanne) ; 10: 1166104, 2023.

Article en En | MEDLINE | ID: mdl-37122327

Palabras clave

Glioblastoma; genomics; glioma; personalised therapy; survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Idioma: En Revista: Front Med (Lausanne) Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google